CHONGQING CHANGYUAN CHEMICAL GROUP CO., LTD. – Trademark Portfolio

Entity Type: 16

CHONGQING CHANGYUAN CHEMICAL GROUP CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include JIALING. The owner is based in CHONGQING CITY.

DUJIABA INDUSTRIAL PARK, RONGCHANG

CHONGQING CITY 402460 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

JIALING
JIALING
Registered 2010

Trademark Classifications

CHONGQING CHANGYUAN CHEMICAL GROUP CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does CHONGQING CHANGYUAN CHEMICAL GROUP CO., LTD. have?

CHONGQING CHANGYUAN CHEMICAL GROUP CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does CHONGQING CHANGYUAN CHEMICAL GROUP CO., LTD. file in?

CHONGQING CHANGYUAN CHEMICAL GROUP CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are CHONGQING CHANGYUAN CHEMICAL GROUP CO., LTD.'s most well-known trademarks?

CHONGQING CHANGYUAN CHEMICAL GROUP CO., LTD.'s registered trademark portfolio includes well-known marks such as JIALING. These are among 1 currently registered trademark in the portfolio.

What is CHONGQING CHANGYUAN CHEMICAL GROUP CO., LTD.'s trademark registration success rate?

CHONGQING CHANGYUAN CHEMICAL GROUP CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.